Translational progress on tumor biomarkers
There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been...
Main Authors: | Guo, Hongwei, Zhou, Xiaolin, Lu, Yi, Xie, Liye, Chen, Qian, Keller, Evan T, Liu, Qian, Zhou, Qinghua, Zhang, Jian |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley & Sons, Ltd
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632916/ |
Similar Items
-
Role of Translationally Controlled Tumor Protein in Cancer Progression
by: Chan, Tim Hon Man, et al.
Published: (2012) -
Screening for biomarkers reflecting the progression of Babesia microti infection
by: Bin Xu, et al.
Published: (2018-07-01) -
Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
by: Xie, Hui, et al.
Published: (2013) -
Wnt3a: functions and implications in cancer
by: He, Sha, et al.
Published: (2015) -
RPFdb: a database for genome wide information of translated mRNA generated from ribosome profiling
by: Xie, Shang-Qian, et al.
Published: (2016)